Develops targeted small molecule drugs by mining fungal genomes using data science and synthetic biology.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics. Their proprietary platform combines data science and synthetic biology to discover and engineer drugs from DNA sequences. They are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.
Hexagon Bio Funding
Sign up to gain insights into Hexagon Bio funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series C | Oct 23, 2026 | 50M | ||
| Series C-1 | Oct 23, 2026 | 8M | ||
| Series C-2 | Oct 23, 2026 | 4M | ||
| Series B | Sep 29, 2022 | 67M | ||
| Series A-Prime | Jun 11, 2021 | 61M | ||
| Series A-1 | Sep 15, 2020 | 27M | ||
| Series A-2 | Apr 09, 2018 | 12M | ||
| Seed | Jun 16, 2017 | 8M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Hexagon Bio Management Team
Investors
8VC
Canada Pension Plan Investment Board
Casdin Capital
Column Group
Deviation Capital
Nextech Invest Ltd.
Softbank Vision Fund 2
Two Sigma Ventures
Hexagon Bio Valuations & Financials
View real-time NPM data on Hexagon Bio stock including daily Hexagon Bio stock price estimates, valuation history, and historical share price information. Access Hexagon Bio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Hexagon Bio pricing across six independent market signals. Looking for private company due diligence data sources on Hexagon Bio? Get in touch to learn more.
Similar Companies
like Hexagon Bio
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Outcomes4Me
Healthcare & Life Sciences
AI-driven platform empowering cancer patients to navigate treatment decisions with personalized guidance on clinical options and trial matching.
Farmstead App
Delivers fresh groceries to your door using AI to optimize sourcing, reduce food waste, and offer same-day service at supermarket prices.
iCounter
Cybersecurity
Delivers proactive intelligence that detects bespoke cyber threats within an organization’s ecosystem and enables precision defense.
Epinoma
Develops a biotechnology platform that replicates low-input genomic samples while preserving methylation markers to enhance early disease detection.
Divert
Climate & Sustainability
A company that provides technological solutions to automate food waste diversion, helping businesses turn waste into sustainable resources.
Haven Energy
Accelerates home battery adoption by guiding installation, financing, and enabling homeowners to earn from grid services through virtual power plants.
Freeform
Industrials
Produces industrial-grade metal components by harnessing AI-driven printing systems to streamline production.
Asylia Therapeutics
Develops medicines that harness antigen presentation to boost immune responses against cancer and autoimmune diseases.
FAQ
We have answers
Hexagon Bio stock does not trade on public stock exchanges. Hexagon Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Hexagon Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Hexagon Bio Stock does not trade on public stock exchanges. In order to sell Hexagon Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Hexagon Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Hexagon Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Hexagon Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Hexagon Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Hexagon Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Hexagon Bio is a private company and has not had an IPO. There is currently no Hexagon Bio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Hexagon Bio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
